Risk stratification in the decision to include prednisolone with intravenous immunoglobulin in primary therapy of Kawasaki disease. (Q45978735)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Risk stratification in the decision to include prednisolone with intravenous immunoglobulin in primary therapy of Kawasaki disease. |
scientific article |
Statements
1 reference
Risk stratification in the decision to include prednisolone with intravenous immunoglobulin in primary therapy of Kawasaki disease. (English)
1 reference
Tohru Kobayashi
1 reference
Yoshinari Inoue
1 reference
Tetsuya Otani
1 reference
Akihiro Morikawa
1 reference
Tomio Kobayashi
1 reference
Kazuo Takeuchi
1 reference
Tsutomu Saji
1 reference
Tomoyoshi Sonobe
1 reference
Shunichi Ogawa
1 reference
Masaru Miura
1 reference
Hirokazu Arakawa
1 reference
1 June 2009
1 reference
28
1 reference
6
1 reference
498-502
1 reference